Concepedia

Helen Eliopoulos

HE

Statistics

Publications

5

Citations

582

H-Index

5

Active since

2008

Affiliations

Sarepta Therapeutics (United States)(Current)

Nationwide Children's Hospital

Helen Eliopoulos is an author at Sarepta Therapeutics (United States) specializing in cancer research, clinical trials, and drug discovery.

Top concepts

Publications per year

2008–2021

5

Publications

5

Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

Shivaani Kummar, Robert J. Kinders, Martin Gutierrez et al. · Journal of Clinical Oncology · 2009 · 324 citations · Full text

Eteplirsen Treatment Attenuates Respiratory Decline in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy

Navid Khan, Helen Eliopoulos, Lixin Han et al. · Journal of Neuromuscular Diseases · 2019 · 93 citations · Full text

Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy

Lindsay N. Alfano, Jay S. Charleston, Anne M. Connolly et al. · Medicine · 2019 · 84 citations · Full text

Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls

Jerry R. Mendell, Navid Khan, Nanshi Sha et al. · Journal of Neuromuscular Diseases · 2021 · 48 citations · Full text

Phase 0 Trials: An Industry Perspective

Helen Eliopoulos, Vincent L. Giranda, Robert A. Carr et al. · Clinical Cancer Research · 2008 · 33 citations

, , +16

1–5 of 5